Patients with NSCLC who experienced a later relapse (after >2 years) revealed an increased CD4+ T cell density in both the tumor core (nonsignificant) and the tumor margin compared to patients with early relapse (<1 year) (Fig. 6F). The gene discussed is CD4; the disease is non-small cell lung carcinoma.